What were Metropolis Healthcare Ltd's latest quarterly results?
Metropolis Healthcare Ltd's latest quarterly results (Dec 2025) show
- PAT Growth YoY: +35.5%
- Revenue Growth YoY: +25.7%
- Operating Margin: 23.0%
Metropolis Healthcare Ltd: Stock Analysis & Fundamentals
Updated this weekMetropolis Healthcare Ltd (Diagnostics) — fundamental analysis, earnings data, and key metrics. PE: 51.1. ROE: 11.5%. This stock is not currently in the Nifty 500 momentum outperformers list.
What's Happening
👔Promoter stake down 0.5% this quarter
🌐FII stake decreased 6.0% this quarter
🏛️DII accumulation — stake up 5.1%
Key Numbers
Current Price
₹431
Dividend Yield
0.23%
Market Cap
8.9K Cr
Valuation
N/AFrequently Asked Questions: Metropolis Healthcare Ltd
Based on publicly available financial data. This is educational research, not investment advice.
What is Metropolis Healthcare Ltd's current PE ratio?
Metropolis Healthcare Ltd's current PE ratio is 51.1x.
- Current PE: 51.1x
- Market Cap: 8.9K Cr
- Dividend Yield: 0.23%
What is Metropolis Healthcare Ltd's price-to-book ratio?
Metropolis Healthcare Ltd's price-to-book ratio is 6.2x.
- Price-to-Book (P/B): 6.2x
- Book Value per Share: ₹69
- Current Price: ₹431
Is Metropolis Healthcare Ltd a fundamentally strong company?
Metropolis Healthcare Ltd's fundamental strength based on key financial ratios
- Return on Capital (ROCE): 15.0%
Is Metropolis Healthcare Ltd debt free?
Metropolis Healthcare Ltd has a debt-to-equity ratio of N/A.
- Total Debt: ₹201 Cr
What is Metropolis Healthcare Ltd's return on equity (ROE) and ROCE?
Metropolis Healthcare Ltd's return ratios over recent years
- FY2023: ROCE 17.0%
- FY2024: ROCE 16.0%
- FY2025: ROCE 15.0%
Is Metropolis Healthcare Ltd's cash flow positive?
Metropolis Healthcare Ltd's operating cash flow is positive (FY2025).
- Cash from Operations (CFO): ₹263 Cr
- Free Cash Flow (FCF): ₹64 Cr
- CFO/PAT Ratio: 180% (strong cash conversion)
What is Metropolis Healthcare Ltd's dividend yield?
Metropolis Healthcare Ltd's current dividend yield is 0.23%.
- Dividend Yield: 0.23%
- Current Price: ₹431
Who holds Metropolis Healthcare Ltd shares — promoters, FII, DII?
Metropolis Healthcare Ltd's shareholding pattern (Dec 2025)
- Promoters: 48.9%
- FII (Foreign): 11.7%
- DII (Domestic): 34.7%
- Public: 4.7%
Is promoter holding increasing or decreasing in Metropolis Healthcare Ltd?
Metropolis Healthcare Ltd's promoter holding has decreased recently.
- Current Promoter Holding: 48.9% (Dec 2025)
- Previous Quarter: 48.9% (Sep 2025)
- Change: -0.02% (decreasing — worth monitoring)
Is Metropolis Healthcare Ltd a new momentum entry or an established outperformer?
Metropolis Healthcare Ltd is an established outperformer with 1 weeks of consecutive Nifty 500 outperformance.
Is Metropolis Healthcare Ltd worth studying for long term investment?
Based on quantitative research signals, here is why Metropolis Healthcare Ltd may be worth studying
- Cash flow is positive — CFO ₹263 Cr
What is the investment thesis for Metropolis Healthcare Ltd?
Metropolis Healthcare Ltd investment thesis summary:
What is the future outlook for Metropolis Healthcare Ltd?
Metropolis Healthcare Ltd's forward outlook based on current data signals
- Insufficient data for a forward assessment — monitoring for more signals
The above FAQs are generated from publicly available earnings data and conference call transcripts. This is educational research only. Sector Alpha is not SEBI registered and does not provide investment advice.